COVID shots for children under 5 could roll out as early as next week

FDA recommends approval of COVID vaccine for children under 5

BOSTON (CBS) - COVID vaccines for kids under five are one step closed to being approved. An FDA panel recommended two options – one from Moderna and one from Pfizer. 

The FDA advisory panel met Wednesday to evaluate the clinical trial data submitted by Pfizer and Moderna in children ages 6 months through 4 years. The committee voted unanimously that the benefits of both vaccines outweigh their risks in children younger than 5. 

According to WBZ-TV's Dr. Mallika Marshall, the FDA will – in all likelihood – authorize the vaccines. Then, a CDC advisory committee will meet to make further recommendations before the CDC director signs off. 

It is possible that shots for children younger than 5 will start rolling out next week. 

The Moderna vaccine would be a quarter of the original adult vaccine – so 25 micrograms – and would be given in two doses four weeks apart. The Pfizer vaccine would be a tenth of the adult dose – so 3 micrograms – and given as a series of three shots, with the second dose three weeks after the first and the third dose eight weeks after the second. 

Parents would be given a choice between the two vaccines. 

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.